Anna Kajaste‐Rudnitski

2.8k total citations
36 papers, 1.6k citations indexed

About

Anna Kajaste‐Rudnitski is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Anna Kajaste‐Rudnitski has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Immunology and 14 papers in Genetics. Recurrent topics in Anna Kajaste‐Rudnitski's work include Virus-based gene therapy research (14 papers), interferon and immune responses (9 papers) and HIV Research and Treatment (9 papers). Anna Kajaste‐Rudnitski is often cited by papers focused on Virus-based gene therapy research (14 papers), interferon and immune responses (9 papers) and HIV Research and Treatment (9 papers). Anna Kajaste‐Rudnitski collaborates with scholars based in Italy, United States and France. Anna Kajaste‐Rudnitski's co-authors include Elisa Vicenzi, Luigi Naldini, Nadir Mechti, Greg J. Towers, Bernhard Gentner, Andrea Di Pietro, Carolina Petrillo, Ivan Cuccovillo, Alexandra Oteiza and Philippe Desprès and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Anna Kajaste‐Rudnitski

33 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Kajaste‐Rudnitski Italy 22 768 610 460 292 287 36 1.6k
Laurent Humeau United States 26 1.1k 1.5× 542 0.9× 822 1.8× 250 0.9× 317 1.1× 64 2.2k
Takuo Mizukami Japan 18 537 0.7× 422 0.7× 232 0.5× 381 1.3× 235 0.8× 67 1.4k
Ang Lin China 23 842 1.1× 948 1.6× 238 0.5× 297 1.0× 377 1.3× 48 2.0k
Anna Cerny United States 25 518 0.7× 1.0k 1.7× 254 0.6× 606 2.1× 304 1.1× 29 1.9k
Nelson C. Di Paolo United States 15 888 1.2× 927 1.5× 753 1.6× 258 0.9× 374 1.3× 20 2.1k
John Hural United States 18 544 0.7× 804 1.3× 234 0.5× 414 1.4× 360 1.3× 35 1.6k
Karen E. Johnson United States 14 657 0.9× 876 1.4× 179 0.4× 657 2.3× 142 0.5× 18 1.7k
Masayuki Kuraoka United States 20 455 0.6× 1.2k 2.0× 206 0.4× 480 1.6× 218 0.8× 44 1.8k
Helen Cumming Australia 10 403 0.5× 667 1.1× 78 0.2× 194 0.7× 187 0.7× 13 1.2k
Yijie Ma China 27 939 1.2× 806 1.3× 301 0.7× 743 2.5× 361 1.3× 50 2.2k

Countries citing papers authored by Anna Kajaste‐Rudnitski

Since Specialization
Citations

This map shows the geographic impact of Anna Kajaste‐Rudnitski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kajaste‐Rudnitski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kajaste‐Rudnitski more than expected).

Fields of papers citing papers by Anna Kajaste‐Rudnitski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kajaste‐Rudnitski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kajaste‐Rudnitski. The network helps show where Anna Kajaste‐Rudnitski may publish in the future.

Co-authorship network of co-authors of Anna Kajaste‐Rudnitski

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kajaste‐Rudnitski. A scholar is included among the top collaborators of Anna Kajaste‐Rudnitski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kajaste‐Rudnitski. Anna Kajaste‐Rudnitski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Barzaghi, Federica, Isabel Pagani, Federico Forneris, et al.. (2024). A novel STING variant triggers endothelial toxicity and SAVI disease. The Journal of Experimental Medicine. 221(9). 6 indexed citations
3.
4.
Ferrari, Samuele, Anastasia Conti, Serena Scala, et al.. (2023). Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy. Cell stem cell. 30(5). 549–570. 26 indexed citations
5.
Ferrari, Samuele, Aurélien Jacob, Stefano Beretta, et al.. (2020). Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking. Nature Biotechnology. 38(11). 1298–1308. 108 indexed citations
6.
Torretta, Simone, Alessandra Scagliola, Luisa Ricci, et al.. (2020). D-mannose suppresses macrophage IL-1β production. Nature Communications. 11(1). 6343–6343. 163 indexed citations
7.
Soldi, Monica, Lucia Sergi Sergi, Giulia Unali, et al.. (2020). Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering. Molecular Therapy — Methods & Clinical Development. 19. 411–425. 25 indexed citations
8.
Kajaste‐Rudnitski, Anna, et al.. (2020). Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineering. Gene Therapy. 28(1-2). 16–28. 21 indexed citations
9.
Petrillo, Carolina, Andrea Calabria, Alessia Capotondo, et al.. (2019). Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically Relevant Ex Vivo Gene Therapy Settings. Human Gene Therapy. 30(9). 1133–1146. 8 indexed citations
10.
Petrillo, Carolina, Lucy Thorne, Giulia Unali, et al.. (2018). Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells. Cell stem cell. 23(6). 820–832.e9. 79 indexed citations
11.
Zonari, Erika, Giacomo Desantis, Carolina Petrillo, et al.. (2017). Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy. Stem Cell Reports. 8(4). 977–990. 117 indexed citations
12.
Chiriacò, Maria Serena, Giada Farinelli, Valentina Capo, et al.. (2014). Dual-regulated Lentiviral Vector for Gene Therapy of X-linked Chronic Granulomatosis. Molecular Therapy. 22(8). 1472–1483. 49 indexed citations
13.
Mascagni, Paolo, et al.. (2012). Assessment of efficacy and safety of pandemic A/H1N1/2009 influenza vaccine in a group of health care workers.. PubMed. 103(3). 220–9. 2 indexed citations
14.
Mariani, Samanta A., Immacolata Brigida, Anna Kajaste‐Rudnitski, et al.. (2012). HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte lines. Blood. 119(9). 2013–2023. 3 indexed citations
15.
Kajaste‐Rudnitski, Anna, Laura Galli, Silvia Nozza, et al.. (2010). Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals. AIDS. 25(2). 177–183. 34 indexed citations
16.
Mertens, Eva, Anna Kajaste‐Rudnitski, Shessy Torres, et al.. (2010). Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b. Virology. 399(1). 176–185. 21 indexed citations
17.
Capua, Ilaria, et al.. (2009). Pandemic Vaccine Preparedness—Have We Left Something Behind?. PLoS Pathogens. 5(6). e1000482–e1000482. 13 indexed citations
18.
Kajaste‐Rudnitski, Anna, et al.. (2009). Restriction factors of retroviral replication: the example of Tripartite Motif (TRIM) protein 5α and 22. Amino Acids. 39(1). 1–9. 12 indexed citations
19.
Pinna, Debora, Pasqua Oreste, Anna Kajaste‐Rudnitski, et al.. (2008). Inhibition of Herpes Simplex Virus Types 1 and 2 In Vitro Infection by Sulfated Derivatives of Escherichia coli K5 Polysaccharide. Antimicrobial Agents and Chemotherapy. 52(9). 3078–3084. 25 indexed citations
20.
Kajaste‐Rudnitski, Anna, Tomoji Mashimo, Marie‐Pascale Frenkiel, et al.. (2005). The 2′,5′-Oligoadenylate Synthetase 1b Is a Potent Inhibitor of West Nile Virus Replication Inside Infected Cells. Journal of Biological Chemistry. 281(8). 4624–4637. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026